US › Healthcare

Phreesia Inc (PHR)

US · Healthcare · Health Information Services

$11.44+1.24%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$130.9M
Revenue YoY
+12.9%
Net profit
$3.0M
Profit YoY
+175.7%
EPS
$0.19
EPS estimate
$0.29
Net margin
2.3%

EPS came in at 0.19 against a street estimate of 0.29 — a miss of 34.5%.

Key statistics

Market cap
$663.2M
P/E
67.1
Forward P/E
14.3
P/B
1.85
Book value
$5.81
EPS (TTM)
$0.16
52-week high
$32.76
52-week low
$7.77
50-day MA
$10.00
200-day MA
$13.66
Beta
0.87

Analyst view

Analysts rate Phreesia Inc a strong buy (15 buy, 0 hold, 0 sell out of 15) with an average price target of $13.94.

Shareholding

Insiders
4.38%
Institutions
97.87%

Largest institutional holders

FundStake
Pale Fire Capital SE13.99%
BlackRock Inc9.58%
Vanguard Group Inc9.29%
Vanguard Portfolio Management, LLC5.40%
Vanguard Capital Management, LLC4.01%
AQR Capital Management LLC3.00%
State Street Corp2.38%
Algert Global LLC2.23%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Phreesia Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.